Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.59 |
| ▸ | GABRD | O14764 | 2/20 | 0.59 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.59 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.59 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.59 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.59 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.59 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.59 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.59 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.59 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.59 |
| ▸ | GABRE | P78334 | 2/20 | 0.59 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.59 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.59 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.59 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31117550 | 1.00 | GABRP (0.59) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL2481632 | 0.95 | GABRP (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL9068637 | 0.94 | PPARA (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL6112733 | 0.94 | PPARA (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL9068780 | 0.94 | PPARA (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL4327627 | 0.94 | PPARA (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1931833 | 0.90 | MAPT (0.52) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL29632107 | 0.90 | ALDH1A1 (0.55) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL343331 | 0.90 | ALDH1A1 (0.55) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL29632227 | 0.90 | ALDH1A1 (0.55) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1595936-B1 | COMPOSITION FOR EXTERNAL USE | VITAMIN C60 BIORES CORP (JP) | 2011-10-19 | — | — | EP | claimed |
| US-20060110743-A1 | Drug evolution: drug design at hot spots | KONISHI YASUO | 2006-05-25 | — | — | US | claimed |
| US-20050008570-A1 | Hydroxypyridonate and hydroxypyrimidinone chelating agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-01-13 | — | — | US | claimed |
| EP-1360485-A2 | DIAGNOSTIC METHODS FOR POMPE DISEASE AND OTHER GLYCOGEN STORAGE DISEASES | DUKE UNIVERSITY (US) | 2003-11-12 | — | — | EP | claimed |
| WO-2002095393-A2 | DRUG EVOLUTION: DRUG DESIGN AT HOT SPOTS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2002-11-28 | — | — | WO | claimed |
| US-20020102737-A1 | Diagnostic methods for pompe disease and other glycogen storage diseases | DUKE UNIVERSITY | 2002-08-01 | — | — | US | claimed |
| WO-2001094941-A2 | DIAGNOSTIC METHODS FOR POMPE DISEASE AND OTHER GLYCOGEN STORAGE DISEASES | UNIV DUKE (US) | 2001-12-13 | — | — | WO | claimed |
| US-6017961-A | Ketamine and n-butyl-p-aminobezoate in PLO | DISCOVER GROWTH FUND, LLC (VI) | 2000-01-25 | — | — | US | claimed |
| EP-0590024-B1 | TOPICAL COMPOSITION ENHANCING HEALING OF HERPES LESIONS | VIRO TEX CORP (US) | 1997-05-02 | — | — | EP | claimed |
| EP-0650511-A4 | PHOTOTRANSCHROMIC INK. | XYTRONYX INC (US) | 1996-04-10 | — | — | EP | claimed |
| EP-0650511-A1 | PHOTOTRANSCHROMIC INK | XYTRONYX, INC. (US) | 1995-05-03 | — | — | EP | claimed |
| US-5296275-A | Water soluble nonionic resin carrier, a light sensitive compound which colors in response to protons, wetting agents, thickeners and flow aids | XYTRONYX, INC. (US) | 1994-03-22 | — | — | US | claimed |
| WO-1994001503-A1 | PHOTOTRANSCHROMIC INK | XYTRONYX, INC. (US) | 1994-01-20 | — | — | WO | claimed |
| EP-4626464-A1 | FEXAMETHODS FOR TREATING INFANTILE-ONSET POMPE DISEASE IN PEDIATRIC PATIENTS | Amicus Therapeutics, Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-4603589-A2 | MICELLAR NANOPARTICLES AND USES THEREOF | Biorchestra Co., Ltd. (KR) | 2025-08-20 | — | — | EP | disclosed |
| EP-3990028-B1 | MICELLAR NANOPARTICLES AND USES THEREOF | BIORCHESTRA CO LTD (KR) | 2025-06-04 | — | — | EP | disclosed |
| US-4259448-A | HYDROPHOBIC CHROMATOGRAPHY | NIPPON SODA COMPANY, LTD. (JP) | 1981-03-31 | — | — | US | disclosed |
| WO-1980002643-A1 | METHOD AND COMPOSITION FOR CONTROLLING CORNEAL HYDRATION | HOLLES LAB INC (US) | 1980-12-11 | — | — | WO | disclosed |
| US-4225675-A | A WATER INSOLUBLE CARRIER BOUND TO A PHENYL AMINE | NIPPON SODA COMPANY, LTD. (JP) | 1980-09-30 | — | — | US | disclosed |
| US-4021471-A | Formamidines useful as ultraviolet light absorbers | GIVAUDAN CORPORATION (US) | 1977-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050008570-A1 | Hydroxypyridonate and hydroxypyrimidinone chelating agents | HAMP, GDI1, MPI | GABRP 1842/4885GABRD 4295/4885GABRA1 3715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.